Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificates for Relevant Products
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
(688289)"Sansure Biotech Inc."Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificates for Relevant Products
Filed with SSE · Stock code 688289 · · 2 pages · Chinese
Summary by 6ix AI
The registration certificates were issued by the National Medical Products Administration, confirming the products' compliance for use in qualitative detection of specific viruses, also on page one.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Release
Story so far
- (688289)"Sansure Biotech Inc."Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on Approval of Registration for Medium-term Notes
- Announcement on Results of Completion of Execution of Certain Shares Held by the Former Shareholder Holding More Than 5% of the Shares
Earlier from Sansure Biotech
- (688289)"Sansure Biotech Inc."Announcement on Implementation of Dividend Distribution for the First Half of 2026
- Announcement on Approval of Registration for Medium-term Notes
- Announcement on Results of Completion of Execution of Certain Shares Held by the Former Shareholder Holding More Than 5% of the Shares
- Announcement on Resignation of the Board Secretary and Designation of the Chairman to Act as the Board Secretary
- Announcement on Resolutions of the 4th Extraordinary General Meeting in 2026
Later from Sansure Biotech
- (688289)"Sansure Biotech Inc."Announcement on Adjustment of the Grant Price under the 2021 Restricted Share Incentive Plan
- (688289)"Sansure Biotech Inc."Announcement on Cancellation of Certain Granted but Unvested Restricted Shares under the 2021 Restricted Share Incentive Plan
- (688289)"Sansure Biotech Inc."Announcement on Resolutions of the 9th Extraordinary Meeting of the 3rd Board of Directors in 2026
- (688289)"Sansure Biotech Inc."Announcement on Satisfaction of Vesting Conditions for the Fourth Vesting Period of Initial Grant and the Third Vesting Period of Reserved Grant under the 2021 Restricted Share Incentive Plan
Follow Sansure Biotech into a list and get an email when it puts out news.
Follow Sansure Biotech